Kyle Sperling
Medical · Lansing, MINPI 1710071295
Payments from drug & device makers
Across 93 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$277
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$268
- Viiv Healthcare Company$251
- Novo Nordisk$154
- Lilly USA, LLC$153
- Axsome Therapeutics, Inc.$139
- plus $764 from 19 others
What the payments were for
- Food & beverage$2,006100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $277 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $268 |
| Viiv Healthcare Company | 15 | $251 |
| Novo Nordisk | 8 | $154 |
| Lilly USA, LLC | 4 | $153 |
| Axsome Therapeutics, Inc. | 2 | $139 |
| Otsuka America Pharmaceutical, Inc. | 7 | $117 |
| AbbVie | 6 | $115 |
| Johnson & Johnson | 4 | $77 |
| Bayer | 3 | $61 |
| Pfizer | 4 | $58 |
| Gilead | 2 | $41 |
| Medtronic | 1 | $35 |
| Travere Therapeutics, Inc. | 2 | $34 |
| GSK | 2 | $32 |
| Myriad Genetic Laboratories, Inc. | 2 | $30 |
| SK Life Science, Inc. | 1 | $28 |
| Myovant Sciences Inc. | 1 | $23 |
| Janssen Scientific Affairs, LLC | 1 | $21 |
| Exact Sciences | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Blue Earth Diagnostics | 1 | $16 |
| Urovant Sciences Inc | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,006 in reported general payments places this provider in the 75th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 40 | $28,279 |
| OzempicSemaglutide | 22 | $23,182 |
| FarxigaDapagliflozin Propanediol | 29 | $23,158 |
| XareltoRivaroxaban | 22 | $21,662 |
| VraylarCariprazine Hcl | 14 | $21,095 |
| EliquisApixaban | 20 | $18,293 |
| JardianceEmpagliflozin | 14 | $11,051 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $9,556 |
| Lurasidone Hcl | 18 | $8,625 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $5,158 |
| Atorvastatin Calcium | 206 | $1,792 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,607 |
| Diclofenac Sodium | 12 | $1,533 |
| Duloxetine Hcl | 27 | $987 |
| Hydroxyzine Hcl | 57 | $779 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $154 | $23,18222 claims |
| Johnson & JohnsonXarelto | $77 | $21,66222 claims |
| AbbVieVraylar | $115 | $21,09514 claims |
| PfizerEliquis | $58 | $18,29320 claims |
| GSKTrelegy Ellipta | $32 | $9,55613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 755 medical providers in Michigan.
Other medical in Lansing
- Aastyn GuarinoLansing$15K
- Jason InmanLansing$14K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.